Senti Biosciences Holdings, Inc. (SNTI)
Senti Biosciences Holdings, Inc. (SNTI) Insider Trading
Directors, officers and holders of more than 10% of SNTI report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 42 most recent of 42 transactions on file: 2 with code P, 4 with code S and 36 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | Lu Timothy K | CEO | F Tax Payment | 157,312 | Not measured | Not measured |
| Oct 21, 2026 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | F Tax Payment | 19,953 | Not measured | Not measured |
| Mar 9, 2026 | Lu Timothy K | CEO | F Tax Payment | 80,666 | Not measured | Not measured |
| Mar 9, 2026 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | F Tax Payment | 10,757 | Not measured | Not measured |
| Feb 2, 2026 | Lu Timothy K | CEO | F Tax Payment | 4,191 | Not measured | Not measured |
| Feb 2, 2026 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | F Tax Payment | 1,384 | Not measured | Not measured |
| Jul 18, 2025 | Baum Bryan Daniel | Director | A Award | 43,900 | Not measured | Not measured |
| Jun 25, 2025 | Schulz Fran | Director | A Award | 21,950 | Not measured | Not measured |
| Jun 25, 2025 | COOPERSTONE BRENDA | Director | A Award | 21,950 | Not measured | Not measured |
| Jun 25, 2025 | Tang Donald F | Director | A Award | 21,950 | Not measured | Not measured |
| Jun 25, 2025 | Collins James J. | Director | A Award | 21,950 | Not measured | Not measured |
| Jun 25, 2025 | Hsiung Feng | Director | A Award | 21,950 | Not measured | Not measured |
| Jun 25, 2025 | Mathers Edward T | Director | A Award | 21,950 | Not measured | Not measured |
| Mar 10, 2025 | BAYER HEALTHCARE LLC | 10% Owner | C Conversion | 2,222,000 | Not measured | Not measured |
| Mar 10, 2025 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | C Conversion | 33,000 | $2.25 | $74,250 |
| Mar 10, 2025 | New Enterprise Associates 15, L.P. | 10% Owner | C Conversion | 3,333 | Not measured | Not measured |
| Mar 10, 2025 | Celadon Partners SPV 24 | 10% Owner | C Conversion | 9,777,000 | Not measured | Not measured |
| Mar 10, 2025 | BAYER HEALTHCARE LLC | 10% Owner | C Conversion | 2,222 | Not measured | Not measured |
| Mar 10, 2025 | Celadon Partners SPV 24 | 10% Owner | C Conversion | 9,777 | Not measured | Not measured |
| Mar 10, 2025 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | C Conversion | 33 | $2250.00 | $74,250 |
| Mar 10, 2025 | New Enterprise Associates 15, L.P. | 10% Owner | C Conversion | 3,333,000 | Not measured | Not measured |
| Mar 7, 2025 | Cross John Harry III | Chief Financial Officer | A Award | 174,200 | Not measured | Not measured |
| Mar 7, 2025 | COOPERSTONE BRENDA | Director | A Award | 43,900 | Not measured | Not measured |
| Mar 7, 2025 | Hsiung Feng | Director | A Award | 43,900 | Not measured | Not measured |
| Mar 7, 2025 | Lu Timothy K | CEO | A Award | 642,358 | Not measured | Not measured |
| Mar 7, 2025 | Mathers Edward T | Director | A Award | 43,900 | Not measured | Not measured |
| Mar 7, 2025 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | A Award | 78,363 | Not measured | Not measured |
| Mar 7, 2025 | Schulz Fran | Director | A Award | 43,900 | Not measured | Not measured |
| Mar 7, 2025 | Collins James J. | Director | A Award | 43,900 | Not measured | Not measured |
| Mar 7, 2025 | Tang Donald F | Director | A Award | 43,900 | Not measured | Not measured |
| Mar 6, 2025 | Lu Timothy K | CEO | A Award | 1,927,073 | Not measured | Not measured |
| Mar 6, 2025 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | A Award | 235,088 | Not measured | Not measured |
| Feb 6, 2025 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | S Sale | 182 | $4.37 | $795 |
| Feb 6, 2025 | Lu Timothy K | CEO | S Sale | 545 | $4.36 | $2,376 |
| Feb 4, 2025 | Lu Timothy K | CEO | S Sale | 3,922 | $4.07 | $15,963 |
| Feb 4, 2025 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | S Sale | 1,297 | $4.07 | $5,279 |
| Dec 9, 2024 | BAYER HEALTHCARE LLC | 10% Owner | P Purchase | 3,333,000 | Not measured | Not measured |
| Dec 9, 2024 | BAYER HEALTHCARE LLC | 10% Owner | P Purchase | 2,222 | Not measured | Not measured |
| Dec 9, 2024 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | A Award | 33 | $2250.00 | $74,250 |
| Dec 9, 2024 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | A Award | 49,500 | Not measured | Not measured |
| Dec 9, 2024 | Schulz Fran | Director | A Award | 12,500 | Not measured | Not measured |
| Dec 9, 2024 | Tang Donald F | Director | A Award | 12,500 | Not measured | Not measured |
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.